PubMed

Words of wisdom. Re: Pathologic characteristics of cancers detected in the Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

Schellhammer PF.

Eur Urol. 2009 Feb;55(2):522-3. No abstract available. PMID: 19606534 [PubMed]Related articles

The COMPARE Registry: Design and Baseline Patterns of Care for Men With Biochemical Failure After Definitive Treatment of Localized Prostate Cancer.

Sartor O, McLeod DG, Halabi S, Schellhammer PF, Scardino PT, D'Amico AV, Bennett C, Wei JT; COMPARE Registry Steering Committee.

Urology. 2009 Jul 7. [Epub ahead of print]PMID: 19589569 [PubMed - as supplied by publisher]Related articles

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.

Higano CS, Schellhammer PF, Small EJ, Burch PA, Nemunaitis J, Yuh L, Provost N, Frohlich MW.

Cancer. 2009 Aug 15;115(16):3670-9.PMID: 19536890 [PubMed - indexed for MEDLINE]Related articles

High-grade prostate cancer and the prostate cancer prevention trial.

Logothetis CJ, Schellhammer PF.

Cancer Prev Res (Phila Pa). 2008 Aug;1(3):151-2. Epub 2008 May 18. No abstract available. PMID: 19138948 [PubMed - indexed for MEDLINE]Related articles

Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids.

White KY, Rodemich L, Nyalwidhe JO, Comunale MA, Clements MA, Lance RS, Schellhammer PF, Mehta AS, Semmes OJ, Drake RR.

J Proteome Res. 2009 Feb;8(2):620-30.PMID: 19128049 [PubMed - indexed for MEDLINE]Related articles

[Comparative study of surgical efficacy in open versus laparoscopic prostatectomy: virtual prostate reconstruction and periprostatic tissue quantification]

Diaz JI, Corica A, McKenzie R, Schellhammer PF.

Actas Urol Esp. 2007 Oct;31(9):1045-55. Spanish. PMID: 18257372 [PubMed - indexed for MEDLINE]Related articlesFree article

Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.

Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW.

J Endourol. 2007 Dec;21(12):1521-31.PMID: 18186694 [PubMed - indexed for MEDLINE]Related articles

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.

Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr, Schellhammer PF.

J Urol. 2007 Dec;178(6):2314-30. Review. No abstract available. PMID: 17993339 [PubMed - indexed for MEDLINE]Related articles

Computer modeling technology to assess extracapsular tissue coverage of whole mount sections after retropubic and laparoscopic radical prostatectomy.

Schellhammer PF, Diaz JI, Fabrizio MD, Davis JW, Given RW, Main B, Chaganty NR, Hussein R, McKenzie R.

J Urol. 2007 Oct;178(4 Pt 1):1301-5. Epub 2007 Aug 14.PMID: 17698100 [PubMed - indexed for MEDLINE]Related articles

Re: choices. M. I. Resnick J Urol 2006; 176: 2342.

Schellhammer PF.

J Urol. 2007 Jul;178(1):353-4. Epub 2007 May 15. No abstract available. PMID: 17507036 [PubMed - indexed for MEDLINE]Related articles

Practical system of assessment: an updated acronym for PSA.

Schellhammer PF.

J Urol. 2007 Jan;177(1):14-5. No abstract available. PMID: 17161992 [PubMed - indexed for MEDLINE]Related articles

Prospective longitudinal comparative study of early health-related quality-of-life outcomes in patients undergoing surgical treatment for localized prostate cancer: a short-term evaluation of five approaches from a single institution.

Ball AJ, Gambill B, Fabrizio MD, Davis JW, Given RW, Lynch DF, Shaves M, Schellhammer PF.

J Endourol. 2006 Oct;20(10):723-31.PMID: 17094746 [PubMed - indexed for MEDLINE]Related articles

Immediate adjuvant intravesical chemotherapy after transurethral resection of bladder tumor.

Schellhammer PF.

Curr Opin Urol. 1998 Sep;8(5):407-9. No abstract available. PMID: 17039020 [PubMed]Related articles

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer.

Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM.

J Clin Oncol. 2006 Jul 1;24(19):3089-94.PMID: 16809734 [PubMed - indexed for MEDLINE]Related articles

Timing of androgen deprivation therapy: some questions answered, others not.

Schellhammer PF.

J Natl Cancer Inst. 2006 Jun 21;98(12):802-3. No abstract available. PMID: 16788149 [PubMed - indexed for MEDLINE]Related articlesFree article

Re: Editorial comment on Laparoscopic radical prostatectomy: is intact organ removal attainable? Study of margin status.

Schellhammer PF.

J Urol. 2006 May;175(5):1963; author reply 1964. No abstract available. PMID: 16600808 [PubMed - indexed for MEDLINE]Related articles

Overexpression of alpha-defensin is associated with bladder cancer invasiveness.

Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A.

Urol Oncol. 2006 Mar-Apr;24(2):97-108.PMID: 16520271 [PubMed - indexed for MEDLINE]Related articles

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study.

Sarosdy MF, Tangen CM, Weiss GR, Nestok BR, Benson MC, Schellhammer PF, Sagalowsky AI, Wood DP Jr, Crawford ED.

Urol Oncol. 2005 Nov-Dec;23(6):386-9.PMID: 16301114 [PubMed - indexed for MEDLINE]Related articles

Laparoscopic radical prostatectomy: evaluation of specimen pathologic features to critically assess and modify surgical technique.

Soderdahl DW, Diaz JI, Rabah DM, Schellhammer PF, Fabrizio MD.

Urology. 2005 Sep;66(3):552-6.PMID: 16140076 [PubMed - indexed for MEDLINE]Related articles

Prospective longitudinal comparative study of health-related quality of life in patients undergoing invasive treatments for localized prostate cancer.

Soderdahl DW, Davis JW, Schellhammer PF, Given RW, Lynch DF, Shaves M, Burke BL, Fabrizio MD.

J Endourol. 2005 Apr;19(3):318-26.PMID: 15865521 [PubMed - indexed for MEDLINE]Related articles

Laparoscopic radical prostatectomy: is intact organ removal attainable? Study of margin status.

Rabah DM, Schellhammer PF, Diaz JI, Tuerk I, Soderdahl DW, Fabrizio MD.

J Endourol. 2004 Oct;18(8):731-4.PMID: 15659892 [PubMed - indexed for MEDLINE]Related articles

Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer.

Schellhammer PF, Hershberg RM.

World J Urol. 2005 Feb;23(1):47-9. Epub 2005 Jan 13.PMID: 15647927 [PubMed - indexed for MEDLINE]Related articles

Protein profiling in urine for the diagnosis of bladder cancer.

Vlahou A, Giannopoulos A, Gregory BW, Manousakas T, Kondylis FI, Wilson LL, Schellhammer PF, Wright GL Jr, Semmes OJ.

Clin Chem. 2004 Aug;50(8):1438-41. No abstract available. PMID: 15277356 [PubMed - indexed for MEDLINE]Related articlesFree article

Contemporary management of prostate cancer with lethal potential.

Davis JW, Shaves ME, Schellhammer PF.

Oncology (Williston Park). 2004 Jun;18(7):811-20; discussion 820-4, 829-32. Review.PMID: 15255168 [PubMed - indexed for MEDLINE]Related articles

Periprostatic lidocaine infiltration and/or synthetic opioid (meperidine or tramadol) administration have no analgesic benefit during prostate biopsy. A prospective randomized double-blind placebo-controlled study comparing different methods.

Bozlu M, Atici S, Ulusoy E, Canpolat B, Cayan S, Akbay E, Schellhammer PF, Oral U.

Urol Int. 2004;72(4):308-11.PMID: 15153728 [PubMed - indexed for MEDLINE]Related articles

Application of a novel protein chip mass spectrometry technology for the identification of bladder cancer-associated biomarkers.

Vlahou A, Schellhammer PF, Wright GL Jr.

Adv Exp Med Biol. 2003;539(Pt A):47-60. Review. No abstract available. PMID: 15088895 [PubMed - indexed for MEDLINE]Related articles

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF, Davis JW.

Clin Prostate Cancer. 2004 Mar;2(4):213-9. Review.PMID: 15072604 [PubMed - indexed for MEDLINE]Related articles

The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies.

Pryor MB, Schellhammer PF.

Clin Prostate Cancer. 2002 Dec;1(3):172-6.PMID: 15046692 [PubMed - indexed for MEDLINE]Related articles

Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy.

Ciavarra RP, Holterman DA, Brown RR, Mangiotti P, Yousefieh N, Wright GL Jr, Schellhammer PF, Glass WF, Somers KD.

J Immunother. 2004 Jan-Feb;27(1):13-26.PMID: 14676630 [PubMed - indexed for MEDLINE]Related articles

Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity?

Bozlu M, Ulusoy E, Doruk E, Cayan S, Canpolat B, Schellhammer PF, Akbay E.

Urology. 2003 Dec;62(6):1050-3.PMID: 14665353 [PubMed - indexed for MEDLINE]Related articles

Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer.

Ciavarra RP, Brown RR, Holterman DA, Garrett M, Glass WF 2nd, Wright GL Jr, Schellhammer PF, Somers KD.

Cancer Immunol Immunother. 2003 Sep;52(9):535-45.PMID: 14627125 [PubMed - indexed for MEDLINE]Related articles

Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.

Somers KD, Brown RR, Holterman DA, Yousefieh N, Glass WF, Wright GL Jr, Schellhammer PF, Qian J, Ciavarra RP.

Int J Cancer. 2003 Dec 10;107(5):773-80.PMID: 14566827 [PubMed - indexed for MEDLINE]Related articles

Editorial: Improving outcomes for primary and salvage therapy of localized prostate cancer.

Schellhammer PF.

J Urol. 2003 Nov;170(5):1841-2. No abstract available. PMID: 14532788 [PubMed - indexed for MEDLINE]Related articles

Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias.

Kondylis FI, Moriarty RP, Bostwick D, Schellhammer PF.

J Urol. 2003 Oct;170(4 Pt 1):1189-93.PMID: 14501722 [PubMed - indexed for MEDLINE]Related articles

Laparoscopic radical prostatectomy: decreasing the learning curve using a mentor initiated approach.

Fabrizio MD, Tuerk I, Schellhammer PF.

J Urol. 2003 Jun;169(6):2063-5.PMID: 12771720 [PubMed - indexed for MEDLINE]Related articles

Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data.

Qu Y, Adam BL, Thornquist M, Potter JD, Thompson ML, Yasui Y, Davis J, Schellhammer PF, Cazares L, Clements M, Wright GL Jr, Feng Z.

Biometrics. 2003 Mar;59(1):143-51.PMID: 12762451 [PubMed - indexed for MEDLINE]Related articles

Sural nerve graft during laparoscopic radical prostatectomy. Initial experience.

Turk IA, Deger S, Morgan WR, Davis JW, Schellhammer PF, Loening SA.

Urol Oncol. 2002 Sep-Oct;7(5):191-4.PMID: 12644215 [PubMed - indexed for MEDLINE]Related articles

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.

Jr GW, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, Schellhammer PF, Gong L, Vlahou A.

Prostate Cancer Prostatic Dis. 1999 Dec;2(5/6):264-276.PMID: 12497173 [PubMed - as supplied by publisher]Related articlesFree article

Re: Trends in Gleason score for prostate cancer diagnosed between 1983 and 1993.

Schellhammer PF.

J Urol. 2002 Dec;168(6):2555-6. No abstract available. PMID: 12441977 [PubMed - indexed for MEDLINE]Related articles

RE: A structured debate: immediate versus deferred androgen suppression in prostate cancer--evidence for deferred treatment.

Schellhammer PF.

J Urol. 2002 Nov;168(5):2130-1; author reply 2131. No abstract available. Erratum in: J Urol. 2003 Feb;169(2):622.. PMID: 12394733 [PubMed - indexed for MEDLINE]Related articles

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

Qu Y, Adam BL, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, Feng Z, Semmes OJ, Wright GL Jr.

Clin Chem. 2002 Oct;48(10):1835-43.PMID: 12324514 [PubMed - indexed for MEDLINE]Related articlesFree article

An evaluation of bicalutamide in the treatment of prostate cancer.

Schellhammer PF.

Expert Opin Pharmacother. 2002 Sep;3(9):1313-28. Review.PMID: 12186624 [PubMed - indexed for MEDLINE]Related articles

Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.

Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, Wright GL Jr.

Clin Cancer Res. 2002 Aug;8(8):2541-52.PMID: 12171882 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr.

Cancer Res. 2002 Jul 1;62(13):3609-14.PMID: 12097261 [PubMed - indexed for MEDLINE]Related articlesFree article

[Laparoscopic radical cystectomy with intracorporeal creation of a continent urinary diversion. Future or present?]

Türk I, Davis JW, Deger S, Winkelmann B, Schönberger B, Schellhammer PF, Loening SA.

Urologe A. 2002 Mar;41(2):107-12. German. PMID: 11993087 [PubMed - indexed for MEDLINE]Related articles

Superficial bladder carcinoma treated with bacillus Calmette-Guerin: progression-free and disease specific survival with minimum 10-year followup.

Davis JW, Sheth SI, Doviak MJ, Schellhammer PF.

J Urol. 2002 Feb;167(2 Pt 1):494-500; discussion 501.PMID: 11792905 [PubMed - indexed for MEDLINE]Related articles

Glansectomy: an alternative surgical treatment for Buschke-Lowenstein tumours of the penis.

Davis JW, Schellhammer PF.

BJU Int. 2001 Oct;88(6):647. No abstract available. PMID: 11678772 [PubMed - indexed for MEDLINE]Related articles

Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position.

Schellhammer PF.

BJU Int. 2001 Oct;88(6):645. No abstract available. PMID: 11678769 [PubMed - indexed for MEDLINE]Related articles

Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease.

Xiao Z, Adam BL, Cazares LH, Clements MA, Davis JW, Schellhammer PF, Dalmasso EA, Wright GL Jr.

Cancer Res. 2001 Aug 15;61(16):6029-33.PMID: 11507047 [PubMed - indexed for MEDLINE]Related articlesFree article

Luteinizing hormone-releasing hormone monotherapy: a viable option for treatment of prostate cancer?

Schellhammer PF.

Urology. 2001 Aug;58(2 Suppl 1):10-5.PMID: 11502437 [PubMed - indexed for MEDLINE]Related articles